The EkoSonic Endovascular System employs high frequency (2-2.5 MHz), low power (0.585 watt averag...
FDA Device Recall #Z-0133-2014 — Class II — October 2, 2013
Recall Summary
| Recall Number | Z-0133-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 2, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | EKOS Corporation |
| Location | Bothell, WA |
| Product Type | Devices |
| Quantity | one unit |
Product Description
The EkoSonic Endovascular System employs high frequency (2-2.5 MHz), low power (0.585 watt average power per transducer) ultrasound to facilitate the delivery of physician-specified fluids in the peripheral vasculature and to deliver solutions into the pulmonary arteries. The EkoSonic Endovascular System is intended for the controlled and selective infusion of physician-specified fluids, including thrombolytics, into the peripheral vasculature and the infusion of solutions into the pulmonary arteries. The reusable EKOS EkoSonic Control Unit provides power to the system and the user interface for operator control. A reusable, non sterile Connector Interface Cable connects the EKOS EkoSonic Control Unit to the EkoSonic Endovascular Device.
Reason for Recall
The EkoSonic Control Unit is recalled because it had the incorrect power entry module installed. It is missing an AC filter to reduce the noise and electrical interference.
Distribution Pattern
Worldwide Distribution in Germany only.
Lot / Code Information
PT3B-783. PT3B represents the model number. Adding 783 creates the serial number.
Other Recalls from EKOS Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2890-2016 | Class II | The EKOS cart has the catalog number 700-60101.... | Aug 22, 2016 |
| Z-2854-2016 | Class II | EkoSonic Endovascular Devices EKOS Intellige... | Aug 9, 2016 |
| Z-0864-2016 | Class II | EkoSonic Endovascular System, Catalog Number 50... | Jan 21, 2016 |
| Z-2148-2015 | Class II | The EKOS EkoSonic Control Unit is intended excl... | Jun 24, 2015 |
| Z-2023-2012 | Class II | EkoSonic MACH4 Endovascular Device (Catalog #50... | May 24, 2012 |
Frequently Asked Questions
Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.